Literature DB >> 615739

Influence of an elemental diet in protein exudation in chronic inflammatory bowel disease.

C K Axelsson, S Jarnum.   

Abstract

13 patients with chronic inflammatory bowel disease were treated with an elemental diet (Vivasorb). Intestinal protein exudation was studied during the treatment by means of of 131I-albumin. 131I-albumin studies showed no significant change of albumin degradation and, by inference, of intestinal protein loss in the group as a whole. A high initial albumin degradation rate augured treatment with elemental diet and prednisone to be unsuccessful. It is concluded that measurement of intestinal protein leakage is of no predictive value as regards the effect of treatment of chronic inflammatory bowel disease with elemental diet. Apparently, diminishing protein exudation is a late phenomenon during a course of clinical remission.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 615739     DOI: 10.1159/000198058

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  3 in total

Review 1.  Evaluation of new therapies for inflammatory bowel disease.

Authors:  E Carty; D S Rampton
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

2.  Reduction of gastrointestinal protein loss by elemental diet in Crohn's disease of the small bowel.

Authors:  R F Logan; J Gillon; C Ferrington; A Ferguson
Journal:  Gut       Date:  1981-05       Impact factor: 23.059

3.  Antiinflammatory treatment and intestinal alpha 1-antitrypsin clearance in active Crohn's disease.

Authors:  U Karbach; K Ewe; H Dehos
Journal:  Dig Dis Sci       Date:  1985-03       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.